Scarica l'app Stockscreener
79.69
0.34%
0.27
Dopo l'orario di chiusura:
79.88
0.19
+0.24%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CVS Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$79.42
Aprire:
$79.75
Volume 24 ore:
5.74M
Relative Volume:
0.78
Capitalizzazione di mercato:
$101.16B
Reddito:
$393.94B
Utile/perdita netta:
$428.00M
Rapporto P/E:
208.29
EPS:
0.3826
Flusso di cassa netto:
$6.29B
1 W Prestazione:
+4.13%
1M Prestazione:
+2.42%
6M Prestazione:
+18.13%
1 anno Prestazione:
+61.41%
Intervallo 1D:
$79.19
$79.90
Intervallo di 1 settimana:
$78.15
$81.08
Portata 52W:
$43.56
$85.15
Cvs Health Corp Stock (CVS) Company Profile
Nome
Cvs Health Corp
Settore
Industria
Telefono
(401) 765-1500
Indirizzo
ONE CVS DR., WOONSOCKET
Confronta CVS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
79.69 | 100.82B | 393.94B | 428.00M | 6.29B | 0.3826 |
|
UNH
Unitedhealth Group Inc
|
341.10 | 309.65B | 435.16B | 18.37B | 17.37B | 19.16 |
|
ELV
Elevance Health Inc
|
360.67 | 79.80B | 194.82B | 5.53B | 3.77B | 24.45 |
|
CI
Cigna Group
|
277.15 | 73.38B | 268.22B | 6.55B | 7.44B | 22.67 |
|
HUM
Humana Inc
|
274.74 | 32.29B | 123.11B | 1.58B | 2.44B | 13.03 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-14 | Iniziato | Goldman | Buy |
| 2025-08-18 | Aggiornamento | UBS | Neutral → Buy |
| 2025-08-14 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | Aggiornamento | Edward Jones | Hold → Buy |
| 2024-12-03 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-11-18 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2024-10-04 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-05-30 | Iniziato | Robert W. Baird | Neutral |
| 2024-05-07 | Downgrade | TD Cowen | Buy → Hold |
| 2024-05-02 | Downgrade | UBS | Buy → Neutral |
| 2024-05-01 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | Iniziato | Barclays | Equal Weight |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2023-12-22 | Iniziato | HSBC Securities | Buy |
| 2023-09-19 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-09-12 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | Downgrade | Edward Jones | Buy → Hold |
| 2023-05-26 | Iniziato | Piper Sandler | Overweight |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Ripresa | Morgan Stanley | Overweight |
| 2022-06-17 | Iniziato | Loop Capital | Buy |
| 2022-05-27 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-02-11 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | Iniziato | Goldman | Buy |
| 2021-12-01 | Iniziato | Seaport Research Partners | Buy |
| 2021-05-19 | Iniziato | Wells Fargo | Equal Weight |
| 2021-03-17 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-01-08 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-09-17 | Iniziato | Piper Sandler | Overweight |
| 2020-07-01 | Iniziato | SVB Leerink | Mkt Perform |
| 2020-05-14 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | Ripresa | RBC Capital Mkts | Outperform |
| 2019-09-12 | Iniziato | Deutsche Bank | Buy |
| 2019-06-05 | Aggiornamento | Standpoint Research | Hold → Buy |
| 2019-04-29 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | Iniziato | Guggenheim | Buy |
| 2019-04-15 | Downgrade | Oppenheimer | Outperform → Perform |
| 2019-04-10 | Reiterato | BofA/Merrill | Buy |
| 2019-03-13 | Iniziato | Bernstein | Outperform |
| 2019-02-20 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | Iniziato | UBS | Buy |
| 2018-12-18 | Iniziato | Barclays | Overweight |
| 2018-11-29 | Ripresa | Goldman | Neutral |
| 2018-11-28 | Iniziato | Evercore ISI | Outperform |
| 2018-10-26 | Ripresa | Wolfe Research | Peer Perform |
| 2018-07-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2018-02-27 | Ripresa | BofA/Merrill | Buy |
| 2018-02-13 | Reiterato | Citigroup | Neutral |
Mostra tutto
Cvs Health Corp Borsa (CVS) Ultime notizie
Press Release: Marsha Blackburn Questions CVS on Rising Health Care Costs and Fraud Allegations - Quiver Quantitative
CVS Stock Gains From Offering MMR Vaccine to South Carolina Residents - TradingView — Track All Markets
CVS Health Shares Navigate Conflicting Market Cues - AD HOC NEWS
National Bank of Canada FI Sells 83,710 Shares of CVS Health Corporation $CVS - MarketBeat
CVS Health (CVS) Adjusts 2026 Revenue Outlook - GuruFocus
Stance Capital LLC Takes $1.99 Million Position in CVS Health Corporation $CVS - MarketBeat
Thompson Davis & CO. Inc. Makes New $1.14 Million Investment in CVS Health Corporation $CVS - MarketBeat
TD Cowen Increases CVS Health (NYSE:CVS) Price Target to $105.00 - MarketBeat
CVS Health Corporation $CVS Stock Holdings Raised by BI Asset Management Fondsmaeglerselskab A S - MarketBeat
Putting pharmacy education within reach - CVS Health
Why CVS Health (CVS) is a Top Momentum Stock for the Long-Term - Yahoo Finance
CVS: Bernstein Raises Price Target for CVS Health to $87 | CVS S - GuruFocus
CVS Health Corporation $CVS Position Raised by Parkwood LLC - MarketBeat
Quantinno Capital Management LP Has $35.79 Million Stake in CVS Health Corporation $CVS - MarketBeat
Bernstein raises CVS Health stock price target to $87 on Aetna growth potential - Investing.com
CVS Health Corporation $CVS is Camber Capital Management LP's 4th Largest Position - MarketBeat
CVS Health offering measles vaccine to South Carolina residents amid the state's current outbreak - Financial Times
The Goldman Sachs Group Boosts CVS Health (NYSE:CVS) Price Target to $95.00 - MarketBeat
Jim Cramer on CVS: "This Stock Has Become the Best Performer in the Healthcare Sector" - Finviz
Jim Cramer on CVS: “This Stock Has Become the Best Performer in the Healthcare Sector” - Insider Monkey
Jim Cramer Recently Commented on These 10 Stocks - Insider Monkey
CVS Health (CVS) Receives Analyst Price Target Upgrade to $98 | - GuruFocus
CVS Health (CVS) Sees Analyst Rating Update from Piper Sandler | - GuruFocus
CVS Health Is Seeing Margin And App Momentum, Analyst Highlights - Benzinga
CVS Health Targets Steady Gains With A Revamped Game Plan - Finimize
CVS Health Stock (CVS) Opinions on 2025 Guidance Update - Quiver Quantitative
CVS Health (CVS) Analysts Maintain Overweight, Raise Price Targe - GuruFocus
UBS Maintains Buy Rating, Raises Price Target for CVS to $97 | C - GuruFocus
CVS Health Raises Its Long-Term Outlook And Stock Follows Suit - Finimize
CVS forecasts 2026 profit higher than Wall Street estimates - Providence Business News
CVS Health Corporation (CVS) Sees Higher Price Target Despite PBM Pressures - Insider Monkey
Mizuho Raises Price Target for CVS Health (CVS) to $95.00 | CVS Stock News - GuruFocus
CVS Health (NYSE:CVS) Price Target Raised to $98.00 at Truist Financial - MarketBeat
CVS Health (NYSE:CVS) Price Target Raised to $95.00 - MarketBeat
CVS Health (CVS) Receives Price Target Increase from Morgan Stan - GuruFocus
Cantor Fitzgerald reiterates Overweight rating on CVS Health stock - Investing.com
Piper Sandler raises CVS Health stock price target to $101 on growth outlook - Investing.com
CVS (CVS) Analyst Rating Update: Baird Raises Price Target to $9 - GuruFocus
CVS Health (NYSE:CVS) Given New $92.00 Price Target at Robert W. Baird - MarketBeat
Investment Management Corp of Ontario Has $5.74 Million Holdings in CVS Health Corporation $CVS - MarketBeat
Intact Investment Management Inc. Sells 20,100 Shares of CVS Health Corporation $CVS - MarketBeat
Morgan Stanley raises CVS Health stock price target to $93 on turnaround - Investing.com
RBC Capital reiterates Outperform rating on CVS Health stock with $93 target - Investing.com
Truist Securities raises CVS Health stock price target to $98 on upbeat outlook - Investing.com
Natixis Has $8.36 Million Stock Position in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Purchased by State Street Corp - MarketBeat
3 Reasons CVS is Risky and 1 Stock to Buy Instead - Finviz
CVS Health stock price target raised to $97 from $96 at UBS - Investing.com
BofA Securities reiterates Buy rating on CVS Health stock with $100 target - Investing.com
Daiwa Securities Group Inc. Purchases 37,509 Shares of CVS Health Corporation $CVS - MarketBeat
CVS Health stock price target raised to $95 by Mizuho on positive outlook - Investing.com
Cvs Health Corp Azioni (CVS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.45%
0.98%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):